Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

Find the latest Drugs in Development and Pipeline Prospector News of KindredBio.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
KindredBio
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
1555 Bayshore Hwy, Suite 200 Burlingame, CA 94010
Telephone
Telephone
(650) 701-7901

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

The collaboration grants Elanco Animal Health an exclusive global rights to KIND-030, a monoclonal antibody targeting canine parvovirus. Under the agreement, KindredBio also has a right of last refusal to manufacture certain of Elanco's other monoclonal antibody products.


Lead Product(s): KIND-030

Therapeutic Area: Infections and Infectious Diseases Product Name: KIND-030

Highest Development Status: Phase IIIProduct Type: Large molecule

Partner/Sponsor/Collaborator: Elanco

Deal Size: $16.5 million Upfront Cash: $0.5 million

Deal Type: Collaboration December 11, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY